» Authors » Malarvizhi Durai

Malarvizhi Durai

Explore the profile of Malarvizhi Durai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 266
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim E, Durai M, Mia Y, Kim H, Moudgil K
Front Immunol . 2016 Jul; 7:203. PMID: 27379088
Heat shock proteins (Hsps) are highly conserved, and their expression is upregulated in cells by heat and other stressful stimuli. These proteins play a vital role in preserving the structural...
2.
Perica K, De Leon Medero A, Durai M, Chiu Y, Bieler J, Sibener L, et al.
Nanomedicine . 2013 Jul; 10(1):119-29. PMID: 23891987
From The Clinical Editor: Artifical antigen presenting cells could revolutionize the field of cancer-directed immunotherapy. This team of investigators have manufactured two types of nanoscale particle platform-based aAPCs and demonstrates...
3.
Gopalakrishnan S, Durai M, Kitchens K, Tamiz A, Somerville R, Ginski M, et al.
Peptides . 2012 Mar; 35(1):86-94. PMID: 22401908
Tight junctions (TJs) control paracellular permeability and apical-basolateral polarity of epithelial cells, and can be regulated by exogenous and endogenous stimuli. Dysregulated permeability is associated with pathological conditions, such as...
4.
Durai M, Huang M, Moudgil K
J Autoimmun . 2009 Oct; 33(3-4):208-13. PMID: 19800761
Heat-shock proteins (Hsps) have been invoked in the pathogenesis of a variety of autoimmune diseases. The mycobacterial heat-shock protein 65 (Bhsp65) has been studied extensively as one of the antigenic...
5.
Moudgil K, Durai M
Trends Immunol . 2008 Aug; 29(9):412-8. PMID: 18675587
Heat-shock proteins (hsps) are highly conserved and immunogenic, and they are generally perceived to be attractive initiators or targets of a pathogenic immune response, and as such, have been implicated...
6.
Durai M, Krueger C, Ye Z, Cheng L, Mackensen A, Oelke M, et al.
Cancer Immunol Immunother . 2008 Jun; 58(2):209-20. PMID: 18563409
Adoptive immunotherapy for treatment of cancers and infectious diseases is often hampered by a high degree of variability in the final T cell product and in the limited in vivo...
7.
Satpute S, Durai M, Moudgil K
Semin Arthritis Rheum . 2008 Jan; 38(3):195-207. PMID: 18177689
Objectives: To review various antigen-specific tolerogenic and immunomodulatory approaches for arthritis in animal models and patients in regard to their efficacy, mechanisms of action, and limitations. Methods: We reviewed the...
8.
Durai M, Kim H, Bala K, Bala K, Moudgil K
J Rheumatol . 2007 Oct; 34(11):2134-43. PMID: 17937454
Objective: In autoimmune situations, the outcome of immune response against a disease-related antigen is typically viewed in terms of the balance between the pathogenic versus the protective subsets of antigen-reactive...
9.
Mia M, Durai M, Kim H, Moudgil K
J Immunol . 2005 Jun; 175(1):219-27. PMID: 15972652
Dimethyl dioctadecyl ammonium bromide (DDA) (C(38)H(80)NBr) is a nonantigenic lipoid material. DDA-induced arthritis (DIA) in the Lewis (LEW) (RT.1(l)) rat is a new experimental model for human rheumatoid arthritis (RA)....
10.
Durai M, Kim H, Moudgil K
J Immunol . 2004 Jun; 173(1):181-8. PMID: 15210773
The 65-kDa mycobacterial heat shock protein (Bhsp65) has been invoked in the pathogenesis of both adjuvant arthritis (AA) in the Lewis rat (RT.1(l)) and human rheumatoid arthritis. Arthritic Lewis rats...